Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,845 | -3,429 | -15,198 | -11,984 | -8,619 |
| Depreciation Amortization | 803 | 406 | 1,698 | 1,266 | 842 |
| Accounts receivable | -1,029 | -214 | -1,208 | -1,348 | -518 |
| Accounts payable and accrued liabilities | 281 | 32 | -1,307 | -647 | -13 |
| Other Working Capital | -2,029 | -952 | -583 | -1,497 | -177 |
| Other Operating Activity | 1,683 | 691 | 4,544 | 3,740 | 1,368 |
| Operating Cash Flow | $-6,136 | $-3,466 | $-12,054 | $-10,470 | $-7,117 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -8 | N/A | -114 | -97 |
| Net Acquisitions | N/A | N/A | -157 | N/A | N/A |
| Investing Cash Flow | $-8 | $-8 | $-157 | $-114 | $-97 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -625 | -313 | -313 | N/A | N/A |
| Common Stock Issued | 4,017 | 3,970 | 661 | N/A | N/A |
| Financing Cash Flow | $3,392 | $3,657 | $348 | $N/A | $N/A |
| Exchange Rate Effect | -1 | -22 | -24 | -4 | -4 |
| Beginning Cash Position | 8,638 | 8,638 | 20,525 | 20,525 | 20,525 |
| End Cash Position | 5,885 | 8,799 | 8,638 | 9,937 | 13,307 |
| Net Cash Flow | $-2,753 | $161 | $-11,887 | $-10,588 | $-7,218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,136 | -3,466 | -12,054 | -10,470 | -7,117 |
| Capital Expenditure | -8 | -8 | N/A | -114 | -97 |
| Free Cash Flow | -6,144 | -3,474 | -12,054 | -10,584 | -7,214 |